Lung Cancer
From the Journals
Can aspirin prolong survival in patients with NSCLC?
“Any potential benefit of aspirin in lung cancer patients needs to be balanced against known adverse events associated with prolonged aspirin use...
Latest News
Common lung cancer screening tool superior to alternatives
CT scans are increasingly used for lung cancer screening, so accuracy is essential in devising an appropriate treatment plan for patients.
Feature
One-quarter of lung cancer patients alive at 5 years
“If you look back, the 5-year survival rate has been very slowly eking up at about 1% over the years.”
Feature
Most oncology trainees encounter discrimination, don’t report it, survey finds
“I thought at some point [the racism and discrimination] would stop, but after all that training. . .I still had to prove myself.”
From the Journals
Substantial declines in mortality for most cancers
“The cancer mortality rate has reduced considerably since 1971 overall and for most cancer sites because of improvements in prevention, early...
Latest News
Now Takeda offers rebate if lung cancer drug fails to work
Brigatinib’s list price is $17,000 for a month’s treatment.
From the Journals
Lung cancer screening rates in U.S. nowhere near goal
Lung cancer screening is effective in reducing mortality, particularly when patients adhere to follow-up recommendations, but too few patients in...
Conference Coverage
Fungal infection can mimic lung cancer metastases
Latest News
Pfizer offers refund if drug ‘doesn’t work’
Although Pfizer claims that its pilot program is a first in the industry, there have been others that are similar.
Latest News
Could your patient benefit? New trials in lung cancer
A rundown of new clinical trials in lung cancer.